Strides Pharma Private Limited

FDA Regulatory Profile

Strides Pharma Private Limited has 0 FDA recalls, 7 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Apr 5, 2024 · VAI

Newer recall under related name Strides Pharma: Oct 7, 2026, D-0079-2027.

Reviewing Strides Pharma Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Strides Pharma Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections7Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Strides Pharma
Same company group
140110Oct 7, 2026 (D-0079-2027)
Strides Pharma Science Limited
Same company group
10131Feb 17, 2020 (D-1029-2020)

Recent FDA Inspections

DateSiteProductClassificationFEI
Apr 5, 2024Chengalpattu, IndiaVeterinaryVoluntary Action Indicated (VAI)3005151016
Aug 9, 2019Chengalpattu, IndiaDrugsNo Action Indicated (NAI)3005151016
Nov 25, 2016Chengalpattu, IndiaDrugsVoluntary Action Indicated (VAI)3005151016
Mar 6, 2015Chengalpattu, IndiaDrugsVoluntary Action Indicated (VAI)3005151016
Sep 13, 2013Chengalpattu, IndiaDrugsVoluntary Action Indicated (VAI)3005151016
Oct 17, 2011Chengalpattu, IndiaDrugsVoluntary Action Indicated (VAI)3005151016
Apr 9, 2009Chengalpattu, IndiaDrugsNo Action Indicated (NAI)3005151016

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3005151016Chengalpattu, India7Apr 5, 2024

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.